This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
Prominent health organizations acknowledge the benefits and lack of side effects of using medical cannabis for controlling chronicpainChronicpain is widely accepted by the medical community to signify disease itself, which can be made much worse by environmental and psychological factors.
Now, patients affected by TRD – who didn’t respond to at least two other antidepressants – no longer need to use an antidepressant in order to benefit from ketamine-based therapy. If you are curious about ketamine therapy for depression, you may still have questions, such as: How is ketamine different from other antidepressants?
No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression. Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life.
In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. However, it is also being used for off-label infusions for the management of psychiatric disorders and chronicpain management (enter the clinics).
CBD has a more subtle interaction, which is why it’s often used for things like anxiety or chronicpain relief without the mind-altering effects. Pain Management and Inflammation CBD’s ability to help with pain management and inflammation is another big reason people are turning to this cannabinoid for relief.
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinicaltrials involving cannabis. Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. AK resident? HI resident? CO resident?
MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes. Supera-CBD is being developed to address anxiety, chronicpain, addiction, and seizures, and is on a path toward human clinicaltrials as a therapy for epilepsy, followed by chronicpain.
Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. This may include opiates for chronicpain, anti-nausea medication, and even antidepressants.
Researchers followed chronicpain patients and found something fascinating: the group using just 2.5 to 5mg of THC got almost the same pain relief as people taking much higher doses we’re talking 64% pain reduction versus 71%. That’s roughly equivalent to a few grains of rice in terms of the actual medicine.
Disease-modifying therapies (DMTs) are essential in altering the immune response to reduce inflammation and prevent further damage to the nervous system. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.
From chronicpain to neurological disorders, understanding the breadth of MMJ’s applications provides a comprehensive view of its role in modern healthcare. Cannabinoids, the active compounds in marijuana, interact with the endocannabinoid system in the body, modulating pain perception and inflammation.
Each type of insomnia may require different treatment approaches, including behavioral therapy, medication, lifestyle changes, or addressing underlying medical or psychological issues. Chronicpain conditions, such as arthritis or back pain, can cause discomfort that interferes with sleep.
(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. No approved TNF inhibitor has ever been dosed orally.
The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.
EXPERIMENTAL pain studies indicate that cannabinoids may be an effective therapy for acute and chronicpain. Have the results of CLINICAL studies also shown that cannabinoids are effective at alleviating acute and chronicpain?
Neuropathic pain, often a chronic and debilitating condition, springs up from damage or dysfunction in the nervous system. Traditional treatments, such as medications and physical therapy, usually fall short of providing effective relief. It is often used to reduce pain and inflammation without causing euphoria or impairment.
In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. The final guideline is expected to be published in November 2019.
The sale will accelerate the development of Gb Sciences’ proprietary Parkinson’s disease and COVID-related Cytokine-Release Syndrome therapies. “We can now concentrate all our energies on advancing our plant-inspired, biopharmaceutical research and development programs into human clinicaltrials.”
a driver of chronic inflammation. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? In addition, the drug is not immunosuppressive and has not been shown to cause the serious side effects common with traditional therapies that treat inflammation. No approved TNF inhibitor has ever been dosed orally.
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronicpain but were unable to answer their patients’ questions” (1).
While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronicpain, nausea, appetite loss, and psychological distress. Besides, its natural origin appeals to patients seeking alternative or complementary therapies.
This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Pain, anxiety and sleep issues are often interconnected – chronicpain can also cause mental health and sleep issues.”. The findings were published today in Frontiers in Pharmacology.
Medical Uses of THC Let’s explore the diverse medical uses of THC, highlighting its efficacy in alleviating chronicpain, its comparison with traditional painkillers, its role in combating nausea and stimulating appetite, its potential benefits for neurological disorders, and its complex interaction with mental health conditions.
The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronicpain, cancer, arthritis, diabetes, depression, anxiety, and many more. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. Key Players.
Veterans seeking alternative therapies, including medical marijuana, may explore the following options: Comprehensive Healthcare Services: The VA provides comprehensive healthcare services, including primary care, specialty care, mental health services, and rehabilitation programs.
Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief. Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronicpain conditions such as arthritis, fibromyalgia, and cancer-related pain.
MYMD-1 has shown effectiveness in pre-clinical studies in regulating the immune system by performing as a selective inhibitor of tumor necrosis factor-alpha (TNF-?), a driver of chronic inflammation. Unlike other therapies, MYMD-1 has been shown in these pre-clinical studies to selectively block TNF-? About Supera-CBD.
Chronicpain. After several trials with traditional forms of therapy and medication with no long-term effectiveness, researchers decided to give CBD oil a shot. Soon, we may even see some large-scale clinicaltrials that can eventually replace dangerous mood-disorder medications like Xanax and Prozac.
In particular, research and development for cannabis-based therapies targeting women’s health challenges is making headway. The female reproductive system has the highest concentration of endocannabinoid receptors after the human brain, making it particularly receptive to cannabis-based therapies.
Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronicpain. Nabiximol is a cannnabis derived drug that exited clinicaltrials in Spain. Acceptance of Medicinal Cannabis.
Crohn’s ), chronicpain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more. While there have been significant studies done over the years, only chronicpain, antiemesis, multiple sclerosis , and sleep have any level of evidence of cannabis effectiveness.
Many turn to cannabis for relaxation, alongside this natural therapy, though some people find that if they have consumed THC, the intoxicating effects can be too distracting when trying to meditate. Both THC and CBD rich products may help those suffering from pain lasting several months. A healthy diet.
(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “For
Therapy is definitely an important route to take, but one reason why CBD products have become so popular as of late is that they help people to better cope with these mental health issues. ChronicPain. Of course, it is yet unknown the extent to which CBD can help more severe cases of depression.
Supera-CBD is currently on a path toward human clinicaltrials as a therapy for epilepsy, followed by chronicpain. The Company’s second drug platform, Supera-CBD, is being developed to treat chronicpain, addiction and epilepsy. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.
MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. a driver of chronic inflammation. Dr. Chapman Bio.
The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronicpain, cancer, arthritis, diabetes, depression, anxiety, and many more. TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. Research programme: cannabidiol therapy.
Medical marijuana (MMJ) is used to treat pain from a wide variety of conditions or illnesses, including everything from chronic back pain to arthritis. There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage.
Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronicpain. Nabiximol is a cannnabis derived drug that exited clinicaltrials in Spain. Acceptance of Medicinal Cannabis.
MYMD-1 has shown effectiveness in pre-clinical studies in regulating the immune system by performing as a selective inhibitor of tumor necrosis factor-alpha (TNF-?), a driver of chronic inflammation. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? No approved TNF inhibitor has ever been dosed orally.
“There’s still a lot we don’t know about medicinal cannabis … when it comes to the pharmacology, what does it do on a molecular level and how does it affect things like chronicpain or symptoms of MS [multiple sclerosis]?”. More recent studies have demonstrated, however, a plausible rationale for therapeutic action.[
We believe VRP324 is the first step toward building our neurological disorder therapy pipeline, expanding the use of our novel delivery platform technologies to multiple categories of neurology,” said Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.
But, if it is consumed along with the right amount of therapy, it might work wonders for PTSD patients. The opioid crisis is a major issue that many Americans suffer from, but many preclinical trials and human clinicaltrials suggest that CBD might help people reduce their dependence on opioids. Helps Relieve Pain.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content